Despite a share price rise, Trinity Biotech's P/S remains lo...
Despite a share price rise, Trinity Biotech's P/S remains low compared to industry medians. Given recent revenue trends, there may not be substantial share price movement without major changes to revenue trends.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000001447431fb34b72.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment